Printer Friendly
The Free Library
14,574,092 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Martin Nutraceuticals Inc. Opens Negotiations to Enter the $900 Million Nutraceutical and Supplement Australian Market.


RENO, NV -- Martin Nutraceuticals Inc. (PINKSHEETS: MNCL MNCL Maintenance Non-Computing (Module) Load .PK) is pleased to announce that it entered into negotiations with JPS JPS Jewish Publication Society
JPS John Peter Smith (Hospital; Texas)
JPS Justice & Public Safety
JPS Jean Piaget Society
JPS Juvenile Polyposis Syndrome
JPS Joint Planning Staff
 Trading Co., a company focused on distribution of supplements and natural products in Australia.

JPS Trading Co. will represent all of Martin's flagship products, Arthrizyme, Oxygenol and Maximum Slim, and will also represent Dr. Martin's book, Medical Crisis - Secrets Your Doctor Won't Share With You. The marketing strategy by JPS will focus on mass distribution of Martin's flagship ingestible products into major retail and supplement centers. The strategy of marketing of the book will follow the North American North American

named after North America.


North American blastomycosis
see North American blastomycosis.

North American cattle tick
see boophilusannulatus.
 model and will be sold through a direct sales DRTV DRTV Direct Response Television (media)  (infomercial) campaign.

"This could be a fantastic opportunity for Martin Nutraceuticals," states Harvey Panesar, President of Martin Nutraceuticals Inc., "We are very excited about the possibilities of entering the Australian market, which is an absolute bonus since we have been focusing on getting our infomercial/DRTV campaign to air in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. . We were not actively searching for other markets outside of North America, but when this opportunity arose, we could not turn it down - it just made sense to at least explore where it could lead."

The Australian market size for nutraceuticals has been consistently rising over the last few years. The current market size for nutraceuticals in Australia has exceeded over $900 million; largely due in part to 60% of the Australian population currently using a nutraceutical product, which equivocates to 7.5 million Australian consumers. Source: Aztec Information System

For more information, please contact Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 at (973) 351-3868 or http://www.martinnutra.com/.

About Martin Nutraceuticals Inc.

Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control.

Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin fibrin: see blood clotting.  in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 27, 2007
Words:460
Previous Article:Avnet Electronics Marketing to Exhibit at CMP Media's Embedded Systems Conference Silicon Valley.
Next Article:Metavante and Monitise To Create Mobile Payments System for North America.
Topics:



Related Articles
CAN THESE BE GOOD FOR YOU?; COMPANIES TOUT FLOOD OF DIETARY SUPPLEMENTS.(L.A. LIFE)(Statistical Data Included)
Q&A : NUTRACEUTICALS DEBATE: WONDER DRUG OR UNNECESSARY SUPPLEMENT?(L.A. LIFE)
Archer Daniels Midland Company, Decatur, Ill., has been awarded a U.S. patent for a range of unique nutraceutical compositions with broad application...
Centre for Functional Foods and Nutraceuticals. (Marketing People).(personnel management)(Brief Article)
Herbal lottery: what's on a dietary supplement's label may not be what's in the bottle.
Growth of bifidobacteria may benefit from selected nutraceuticals.
Martin Nutraceuticals Releases Management Discussion.
Martin Nutraceuticals Inc. Opens Negotiations to Enter the Australian Market.
Martin Nutraceuticals Inc. in Negotiations with X Consul Group for Marketing and Distribution Rights of Its Products in Spain and Portugal.
Increasing Prevalence Of Lifestyle Diseases Drives Demand For Nutraceuticals In Australia And New Zealand.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles